Investigation of Potential Action on Behalf of Alere, Inc. (NYSE: ALR)
Kessler Topaz Meltzer & Check, LLP is investigating a potential shareholder action on behalf of current shareholders of Alere, Inc. (“Alere”).
About Alere, Inc.
Alere provides professional diagnostic products and services for infectious and cardio-metabolic disease, and toxicology in the United States, Europe, and internationally. The company’s infectious disease products and services are used to detect various diseases, such as: viral hepatitis; respiratory syncytial virus; influenza; streptococcus; pneumonia; tuberculosis; human immunodeficiency virus/acquired immunodeficiency syndrome; and gastrointestinal and vector-borne diseases, as well as syphilis and other sexually-transmitted diseases.
Alleged Wrongful Conduct
Kessler Topaz Meltzer & Check, LLP is investigating potential breaches of fiduciary duties by members of Alere’s Board of Directors, which may have caused harm to the company and its shareholders.
If you currently own shares of Alere, Inc. (NYSE: ALR) and would like to learn more about our investigation, please fill out our online form or contact us today at 888-299-7706 or email@example.com.